Business Description
ISIN : US2289031005
Share Class Description:
AORT: Ordinary SharesTotal Employee Number:
1,800Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.92 | |||||
Debt-to-EBITDA | 7.99 | |||||
Interest Coverage | 0.56 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.97 | |||||
Beneish M-Score | -2.67 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.1 | |||||
3-Year EBITDA Growth Rate | 28.2 | |||||
3-Year EPS without NRI Growth Rate | 132.7 | |||||
3-Year Book Growth Rate | 10 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 11.21 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 25.11 | |||||
9-Day RSI | 39.25 | |||||
14-Day RSI | 46.35 | |||||
3-1 Month Momentum % | 12.56 | |||||
6-1 Month Momentum % | -29.35 | |||||
12-1 Month Momentum % | -41.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.47 | |||||
Quick Ratio | 2.51 | |||||
Cash Ratio | 0.72 | |||||
Days Inventory | 204.72 | |||||
Days Sales Outstanding | 71.09 | |||||
Days Payable | 39.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.8 | |||||
Shareholder Yield % | 3.22 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 64.37 | |||||
Operating Margin % | 2.89 | |||||
Net Margin % | -0.67 | |||||
EBITDA Margin % | 10.83 | |||||
FCF Margin % | -1.94 | |||||
OCF Margin % | 8.85 | |||||
ROE % | -0.72 | |||||
ROA % | -0.35 | |||||
3-Year ROIIC % | 14.84 | |||||
ROC (Joel Greenblatt) % | 9.43 | |||||
ROCE % | 3.25 | |||||
Years of Profitability over Past 10-Year | 4 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 312.49 | |||||
PE Ratio without NRI | 48.61 | |||||
PEG Ratio | 2.38 | |||||
PS Ratio | 2.75 | |||||
PB Ratio | 2.87 | |||||
Price-to-Operating-Cash-Flow | 31.28 | |||||
EV-to-EBIT | 60.77 | |||||
EV-to-EBITDA | 31.54 | |||||
EV-to-Revenue | 3.42 | |||||
EV-to-Forward-Revenue | 3.28 | |||||
EV-to-FCF | -175.88 | |||||
Price-to-GF-Value | 0.91 | |||||
Price-to-Projected-FCF | 4.05 | |||||
Price-to-DCF (Earnings Based) | 4.21 | |||||
Price-to-Median-PS-Value | 0.85 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.6 | |||||
Earnings Yield (Greenblatt) % | 1.65 | |||||
FCF Yield % | -0.72 | |||||
Forward Rate of Return (Yacktman) % | 18.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:AORT
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Artivion Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 471.474 | ||
| EPS (TTM) ($) | -0.07 | ||
| Beta | 1.5763 | ||
| 3-Year Sharpe Ratio | 0.44 | ||
| 3-Year Sortino Ratio | 0.78 | ||
| Volatility % | 64.8 | ||
| 14-Day RSI | 46.35 | ||
| 14-Day ATR ($) | 1.208598 | ||
| 20-Day SMA ($) | 27.627 | ||
| 12-1 Month Momentum % | -41.98 | ||
| 52-Week Range ($) | 19.16 - 48.25 | ||
| Shares Outstanding (Mil) | 48.76 |
Piotroski F-Score Details
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Artivion Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Artivion Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-02-18 | In 176 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-02-12 16:30 | In 171 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-12 | In 170 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-06 16:30 | In 73 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 72 days | ||
| Canaccord Genuity 46th Annual Growth Conference | 2026-08-12 09:30 | 28.39 (+8.11%) | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 16:30 | 26.17 (-2.24%) | ||
| Second quarter earnings results for 2026 | 2026-08-06 | 26.17 (-2.24%) | ||
| Guidance call for 2026 | 2026-06-16 13:00 | 21.07 (+3.49%) | ||
| General meeting for 2026 | 2026-05-12 09:00 | 23.81 (-7.78%) |
Artivion Inc Frequently Asked Questions
Guru Commentaries on NYSE:AORT
Artivion, Inc. (AORT) experienced a decline in stock performance due to weaker-than-expected first quarter stent graft sales, which fell short of demand expectations. This was attributed to slower-than-anticipated adoption of their products and softer international demand. Despite management indicating that reorder activity remains strong and expecting adoption to accelerate as hospitals complete the approval process, the stock weakened significantly during the quarter.
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues used in cardiac and vascular surgical procedures, focusing on treating patients with aortic disease. During the quarter, shares detracted from performance after the company reported in-line first-quarter results but modestly lowered its full-year outlook, primarily due to slower-than-expected starter set sales for AMDS, its key new product cycle.
Artivion (AORT) received positive data for two product lines, indicating strong potential for growth. The company is positioned well within the health care sector, which has shown resilience despite broader market challenges. The manager believes that the current market environment, characterized by low valuations for small caps, presents a favorable opportunity for Artivion to appreciate significantly as the market shifts towards smaller stocks. This aligns with the overall strategy of investing in quality growth companies that exhibit stable and consistent growth.
Press Release
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
